I-MAB (IMAB)
1.76
-0.01
(-0.56%)
USD |
NASDAQ |
May 17, 16:00
1.76
0.00 (0.00%)
After-Hours: 20:00
I-MAB Cash from Operations (Quarterly)
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2020 | -84.15M |
| September 30, 2019 | -92.93M |
| Date | Value |
|---|---|
| September 30, 2018 | -22.71M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-92.93M
Minimum
Sep 2019
-84.15M
Maximum
Sep 2020
-88.54M
Average
-88.54M
Median
Cash from Operations (Quarterly) Benchmarks
| Summit Therapeutics Inc | -30.13M |
| Verastem Inc | -28.31M |
| CEL-SCI Corp | -4.528M |
| AIM ImmunoTech Inc | -9.758M |
| IGC Pharma Inc | -1.587M |
Cash from Operations (Quarterly) Related Metrics
| Free Cash Flow Yield | -115.2% |